{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:39:35Z","timestamp":1787992775511,"version":"build-2784847793"},"reference-count":55,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1001\/jamaophthalmol.2019.0900","type":"journal-article","created":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T16:47:46Z","timestamp":1556815666000},"page":"756","source":"Crossref","is-referenced-by-count":34,"title":["Association of Statin Use and High Serum Cholesterol Levels With Risk of Primary Open-Angle Glaucoma"],"prefix":"10.1001","volume":"137","author":[{"given":"Jae H.","family":"Kang","sequence":"first","affiliation":[{"name":"Channing Division of Network Medicine, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahani","family":"Boumenna","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Stein","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor"},{"name":"Center for Eye Policy and Innovation, University of Michigan, Ann Arbor"},{"name":"Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Khawaja","sequence":"additional","affiliation":[{"name":"National Institute for Health Research Biomedical Research Centre, Moorfields Eye Hospital National Health Service Foundation Trust, University College London Institute of Ophthalmology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard A.","family":"Rosner","sequence":"additional","affiliation":[{"name":"Channing Division of Network Medicine, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janey L.","family":"Wiggs","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis R.","family":"Pasquale","sequence":"additional","affiliation":[{"name":"Channing Division of Network Medicine, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston"},{"name":"now with Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"eoi190019r1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/ajcn\/79.5.727","article-title":"Polyphenols: food sources and bioavailability.","volume":"79","author":"Manach","year":"2004","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"eoi190019r2","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: recommendation statement.","volume":"95","author":"US Preventive Services Task Force","year":"2017","journal-title":"Am Fam Physician"},{"issue":"20","key":"eoi190019r3","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS: Air Force\/Texas Coronary Atherosclerosis Prevention Study.","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"issue":"12","key":"eoi190019r4","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1161\/STROKEAHA.108.516450","article-title":"Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.","volume":"39","author":"Sillesen","year":"2008","journal-title":"Stroke"},{"issue":"1","key":"eoi190019r5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2012.04.011","article-title":"Statins and cancer: current and future prospects.","volume":"324","author":"Osmak","year":"2012","journal-title":"Cancer Lett"},{"issue":"2","key":"eoi190019r6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.atherosclerosis.2008.08.022","article-title":"The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis.","volume":"203","author":"Blum","year":"2009","journal-title":"Atherosclerosis"},{"issue":"1","key":"eoi190019r7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/bjc.2016.149","article-title":"Statin use and all-cancer survival: prospective results from the Women\u2019s Health Initiative.","volume":"115","author":"Wang","year":"2016","journal-title":"Br J Cancer"},{"issue":"9426","key":"eoi190019r8","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","article-title":"Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial.","volume":"363","author":"McCarey","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"eoi190019r9","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1586\/14737175.8.5.827","article-title":"Potential therapeutic role of statins in neurological disorders.","volume":"8","author":"Bifulco","year":"2008","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"eoi190019r10","first-page":"79","article-title":"Statin-mediated protective effects in the central nervous system: general mechanisms and putative role of stress proteins.","volume":"24","author":"Schmeer","year":"2006","journal-title":"Restor Neurol Neurosci"},{"issue":"6","key":"eoi190019r11","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/jnc.2005.92.issue-6","article-title":"Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones.","volume":"92","author":"B\u00f6sel","year":"2005","journal-title":"J Neurochem"},{"issue":"3","key":"eoi190019r12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2165\/00063030-200721030-00004","article-title":"Rho GTPase\/rho kinase inhibition as a novel target for the treatment of glaucoma.","volume":"21","author":"Rao","year":"2007","journal-title":"BioDrugs"},{"issue":"11","key":"eoi190019r13","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1167\/iovs.07-1597","article-title":"Statins modulate heat shock protein expression and enhance retinal ganglion cell survival after transient retinal ischemia\/reperfusion in vivo.","volume":"49","author":"Schmeer","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"eoi190019r14","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1111\/jnc.2007.100.issue-4","article-title":"Pitavastatin prevents NMDA-induced retinal ganglion cell death by suppressing leukocyte recruitment.","volume":"100","author":"Nakazawa","year":"2007","journal-title":"J Neurochem"},{"issue":"2","key":"eoi190019r15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.nbd.2005.08.003","article-title":"Simvastatin promotes heat shock protein 27 expression and Akt activation in the rat retina and protects axotomized retinal ganglion cells in vivo.","volume":"21","author":"Kretz","year":"2006","journal-title":"Neurobiol Dis"},{"issue":"5","key":"eoi190019r16","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1167\/iovs.10-6005","article-title":"Simvastatin improves retinal ganglion cell survival and spatial vision after acute retinal ischemia\/reperfusion in mice.","volume":"52","author":"Krempler","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"eoi190019r17","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.exer.2011.07.003","article-title":"Simvastatin upregulates Bcl-2 expression and protects retinal neurons from early ischemia\/reperfusion injury in the rat retina.","volume":"93","author":"Ko","year":"2011","journal-title":"Exp Eye Res"},{"issue":"11","key":"eoi190019r18","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1080\/02713680701649603","article-title":"Pitavastatin: protection against neuronal retinal damage induced by ischemia-reperfusion injury in rats.","volume":"32","author":"Kawaji","year":"2007","journal-title":"Curr Eye Res"},{"issue":"6","key":"eoi190019r19","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1001\/archopht.122.6.822","article-title":"Statins and other cholesterol-lowering medications and the presence of glaucoma.","volume":"122","author":"McGwin","year":"2004","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"eoi190019r20","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1016\/j.ophtha.2012.04.029","article-title":"The relationship between statin use and open-angle glaucoma.","volume":"119","author":"Stein","year":"2012","journal-title":"Ophthalmology"},{"issue":"1","key":"eoi190019r21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029724","article-title":"Cholesterol-lowering drugs and incident open-angle glaucoma: a population-based cohort study.","volume":"7","author":"Marcus","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"eoi190019r22","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1167\/iovs.09-4821","article-title":"Hypotensive medication, statins, and the risk of glaucoma.","volume":"51","author":"Owen","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"45","key":"eoi190019r23","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002018","article-title":"Association between statin use and open-angle glaucoma in hyperlipidemia patients: a Taiwanese population-based case-control study.","volume":"94","author":"Chen","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"eoi190019r24","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1167\/iovs.15-18595","article-title":"The effect of statins on intraocular pressure and on the incidence and progression of glaucoma: a systematic review and meta-analysis.","volume":"57","author":"McCann","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"14","key":"eoi190019r25","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.1167\/iovs.16-20233","article-title":"Author response: a meta-analysis of glaucoma risk in hyperlipidemic individuals: a critical problem in design.","volume":"57","author":"McCann","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"14","key":"eoi190019r26","doi-asserted-by":"publisher","first-page":"6339","DOI":"10.1167\/iovs.16-20099","article-title":"A meta-analysis of glaucoma risk in hyperlipidemic individuals: a critical problem in design.","volume":"57","author":"Hwang","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"eoi190019r27","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2105\/AJPH.70.8.823","article-title":"Characteristics of respondents and non-respondents to a mailed questionnaire.","volume":"70","author":"Barton","year":"1980","journal-title":"Am J Public Health"},{"issue":"9","key":"eoi190019r28","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.2105\/AJPH.2016.303338","article-title":"Origin, methods, and evolution of the Three Nurses\u2019 Health Studies.","volume":"106","author":"Bao","year":"2016","journal-title":"Am J Public Health"},{"issue":"15","key":"eoi190019r29","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1056\/NEJM199010113231504","article-title":"Coffee, caffeine, and cardiovascular disease in men.","volume":"323","author":"Grobbee","year":"1990","journal-title":"N Engl J Med"},{"issue":"6","key":"eoi190019r30","doi-asserted-by":"publisher","first-page":"e692","DOI":"10.1111\/aos.13705","article-title":"Prospective study of flavonoid intake and risk of primary open-angle glaucoma.","volume":"96","author":"Kang","year":"2018","journal-title":"Acta Ophthalmol"},{"issue":"19","key":"eoi190019r31","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1001\/archinte.165.19.2264","article-title":"Serum lipids, lipid-lowering drugs, and the risk of breast cancer.","volume":"165","author":"Eliassen","year":"2005","journal-title":"Arch Intern Med"},{"issue":"6","key":"eoi190019r33","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/oxfordjournals.aje.a009849","article-title":"Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements.","volume":"149","author":"Hu","year":"1999","journal-title":"Am J Epidemiol"},{"issue":"5","key":"eoi190019r35","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/(ISSN)1097-0258","article-title":"Flexible regression models with cubic splines.","volume":"8","author":"Durrleman","year":"1989","journal-title":"Stat Med"},{"issue":"9","key":"eoi190019r36","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs.","volume":"158","author":"Ray","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"11","key":"eoi190019r37","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/oxfordjournals.aje.a009758","article-title":"Confounding by indication: an example of variation in the use of epidemiologic terminology.","volume":"149","author":"Salas","year":"1999","journal-title":"Am J Epidemiol"},{"issue":"3","key":"eoi190019r38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1001\/jamaophthalmol.2016.5406","article-title":"Association of daily dosage and type of statin agent with risk of open-angle glaucoma.","volume":"135","author":"Talwar","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"12","key":"eoi190019r39","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1161\/01.RES.0000196564.18314.23","article-title":"Rho GTPases, statins, and nitric oxide.","volume":"97","author":"Rikitake","year":"2005","journal-title":"Circ Res"},{"issue":"11","key":"eoi190019r40","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1167\/iovs.05-0164","article-title":"Blebbistatin, a novel inhibitor of myosin II ATPase activity, increases aqueous humor outflow facility in perfused enucleated porcine eyes.","volume":"46","author":"Zhang","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"eoi190019r41","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1167\/iovs.04-0776","article-title":"Effects of cholesterol-lowering statins on the aqueous humor outflow pathway.","volume":"46","author":"Song","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"eoi190019r42","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S1350-9462(01)00014-3","article-title":"Role of nitric oxide in the control of ocular blood flow.","volume":"20","author":"Schmetterer","year":"2001","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"eoi190019r43","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/archopht.124.5.665","article-title":"Effect of systemic administration of simvastatin on retinal circulation.","volume":"124","author":"Nagaoka","year":"2006","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"eoi190019r44","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.pneurobio.2009.02.002","article-title":"Statins: mechanisms of neuroprotection.","volume":"88","author":"van der Most","year":"2009","journal-title":"Prog Neurobiol"},{"issue":"33","key":"eoi190019r45","doi-asserted-by":"publisher","first-page":"13444","DOI":"10.1073\/pnas.0703707104","article-title":"Targeting amyloid-\u00df in glaucoma treatment.","volume":"104","author":"Guo","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"37","key":"eoi190019r46","doi-asserted-by":"publisher","first-page":"26832","DOI":"10.1074\/jbc.M702640200","article-title":"Statins reduce amyloid-\u00df production through inhibition of protein isoprenylation.","volume":"282","author":"Ostrowski","year":"2007","journal-title":"J Biol Chem"},{"issue":"4","key":"eoi190019r47","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.survophthal.2012.08.010","article-title":"The role of inflammation in the pathogenesis of glaucoma.","volume":"58","author":"Vohra","year":"2013","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"eoi190019r48","doi-asserted-by":"publisher","first-page":"282","DOI":"10.2174\/187152707781387260","article-title":"Therapeutic potential of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for the treatment of retinal and eye diseases.","volume":"6","author":"Schmeer","year":"2007","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"12","key":"eoi190019r49","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1001\/archopht.120.12.1707","article-title":"Statin inhibits leukocyte-endothelial interaction and prevents neuronal death induced by ischemia-reperfusion injury in the rat retina.","volume":"120","author":"Honjo","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"35","key":"eoi190019r50","doi-asserted-by":"publisher","first-page":"11104","DOI":"10.1523\/JNEUROSCI.23-35-11104.2003","article-title":"3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity.","volume":"23","author":"Zacco","year":"2003","journal-title":"J Neurosci"},{"issue":"10","key":"eoi190019r51","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/eye.2015.160","article-title":"Genes, pathways, and animal models in primary open-angle glaucoma.","volume":"29","author":"Iglesias","year":"2015","journal-title":"Eye (Lond)"},{"issue":"1","key":"eoi190019r52","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1038\/s41467-018-04555-4","article-title":"A multiethnic genome-wide association study of primary open-angle glaucoma identifies novel risk loci.","volume":"9","author":"Choquet","year":"2018","journal-title":"Nat Commun"},{"issue":"4","key":"eoi190019r53","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4236\/ojoph.2014.44021","article-title":"The emerging role of statins in glaucoma pathological mechanisms and therapeutics.","volume":"4","author":"Pokrovskaya","year":"2014","journal-title":"Open J Ophthalmol"},{"issue":"3","key":"eoi190019r54","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/09286586.2017.1399427","article-title":"The influence of oral statin medications on progression of glaucomatous visual field loss: a propensity score analysis.","volume":"25","author":"Whigham","year":"2018","journal-title":"Ophthalmic Epidemiol"},{"key":"eoi190019r32","doi-asserted-by":"crossref","DOI":"10.1093\/acprof:oso\/9780195122978.001.0001","volume-title":"Nutritional Epidemiology","author":"Willett","year":"1998","edition":"2nd ed"},{"key":"eoi190019r34","volume-title":"The Analysis of Survival Data","author":"Cox","year":"1984"},{"key":"eoi190019r55","volume-title":"Modern Epidemiology","author":"Rothman","year":"1998","edition":"2nd ed"}],"updated-by":[{"DOI":"10.1001\/jamaophthalmol.2020.0027","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"record-id":"22847"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2732293\/jamaophthalmology_kang_2019_oi_190019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T16:00:46Z","timestamp":1584028846000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2732293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":55,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.0900","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7,1]]}}}